Alto Neuroscience, Inc.

Alto Neuroscience, Inc.verified

ANRO

Price:

$15.13

Market Cap:

$470.03M

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO...[Read more]

Industry

Biotechnology

IPO Date

2024-02-02

Stock Exchange

NYSE

Ticker

ANRO

The Current Ratio as of December 2025 (TTM) for Alto Neuroscience, Inc. (ANRO) is 18.43

According to Alto Neuroscience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.43. This represents a change of 3.88% compared to the average of 17.75 of the last 4 quarters.

Alto Neuroscience, Inc. (ANRO) Historical Current Ratio (quarterly & annually)

How has ANRO Current Ratio performed in the past?

The mean historical Current Ratio of Alto Neuroscience, Inc. over the last ten years is 14.07. The current 18.43 Current Ratio has changed 13.00% with respect to the historical average. Over the past ten years (40 quarters), ANRO's Current Ratio was at its highest in in the March 2024 quarter at 26.02. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Quarterly (TTM)
Annual

Average

14.07

Median

15.26

Minimum

8.85

Maximum

16.92

Alto Neuroscience, Inc. (ANRO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alto Neuroscience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.94%

Maximum Annual Current Ratio = 16.92

Minimum Annual Increase = -42.12%

Minimum Annual Current Ratio = 8.85

Quarterly (TTM)
Annual
YearCurrent RatioChange
202416.9211.16%
202315.2271.94%
20228.85-42.12%

Alto Neuroscience, Inc. (ANRO) Average Current Ratio

How has ANRO Current Ratio performed in the past?

The current Current Ratio of Alto Neuroscience, Inc. (ANRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

13.66

5-year avg

14.07

10-year avg

14.07

Alto Neuroscience, Inc. (ANRO) Current Ratio vs. Peers

How is ANRO’s Current Ratio compared to its peers?

Alto Neuroscience, Inc.’s Current Ratio is greater than Cellectis S.A. (1.38), greater than AC Immune S.A. (1.33), greater than Amarin Corporation plc (3.45), greater than Larimar Therapeutics, Inc. (5.46), less than Contineum Therapeutics, Inc. Class A Common Stock (29.07), greater than Aldeyra Therapeutics, Inc. (2.86), greater than Alpha Tau Medical Ltd. (8.43), greater than Silence Therapeutics plc (7.69), greater than Korro Bio, Inc. (5.98), greater than DBV Technologies S.A. (2.45),

Build a custom stock screener for Alto Neuroscience, Inc. (ANRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alto Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alto Neuroscience, Inc. (ANRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alto Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Alto Neuroscience, Inc.'s Current Ratio?

How is the Current Ratio calculated for Alto Neuroscience, Inc. (ANRO)?

What is the highest Current Ratio for Alto Neuroscience, Inc. (ANRO)?

What is the 3-year average Current Ratio for Alto Neuroscience, Inc. (ANRO)?

What is the 5-year average Current Ratio for Alto Neuroscience, Inc. (ANRO)?

How does the current Current Ratio for Alto Neuroscience, Inc. (ANRO) compare to its historical average?